Vaccine against cancerous diseases
CA 2405290 C · Owner: Bio Life Science Forschungs Und Entwicklungsgesellschaft Mbh · Inventors: Breiteneder, Heimo; Scheiner, Otto; Zielinski, Christoph
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for producing a vaccine against cancerous , diseases, and the vaccine itself. This method involves first using one or more antibodies , that are specifically effective against one or more antigens specially expressed , by the tumor cells to select one or more mimotopes of said antigens from a phage peptide , library. To obtain the vaccine said mimotopes are conjugated to a , macromolecular carrier singly or multiply in the form of their monodi-, tri- or oligomers. , When , administered the inventively produced vaccine leads to a humoral immune response , and thus to the formation of an active immunity as a consequence of vaccination.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 2001 and granted June 21, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.